These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2025824)

  • 21. [Plasma lipoproteins and apolipoproteins. Value of their determination in the detection of coronary atherosclerosis. Comparison with data supplied by coronarography].
    Fruchart JC; Bertrand M; Parra H; Gentilini JL; Boniface B; Boniface M
    Nouv Presse Med; 1982 Nov; 11(47):3491-4. PubMed ID: 6818524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic value of serum lipid and apolipoprotein parameters for the detection of a coronary risk even in the range of nonpathological serum cholesterol and triglyceride values].
    Winkler L; Schlag B; Ostermann G; Dargel R
    Z Med Lab Diagn; 1988; 29(6):314-20. PubMed ID: 3188608
    [No Abstract]   [Full Text] [Related]  

  • 23. Utility of different lipid measures to predict coronary heart disease.
    Remick J; Underberg JA; Shah NR
    JAMA; 2008 Jan; 299(1):35-6; author reply 36. PubMed ID: 18167402
    [No Abstract]   [Full Text] [Related]  

  • 24. Utility of different lipid measures to predict coronary heart disease.
    Sierra-Johnson J; Romero-Corral A; Lopez-Jimenez F
    JAMA; 2008 Jan; 299(1):35; author reply 36. PubMed ID: 18167403
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum triglyceride concentration and coronary heart disease.
    Schillaci G; Pirro M; Mannarino E
    Circulation; 2002 Feb; 105(8):e54. PubMed ID: 11864938
    [No Abstract]   [Full Text] [Related]  

  • 26. [Protein C and apoprotein levels in ischemic heart disease diagnosed by coronarography].
    Orosz L; Altorjay I; Hársfalvl J; Voith L
    Orv Hetil; 1989 May; 130(19):987-9. PubMed ID: 2657571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism.
    Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
    J Cardiovasc Risk; 1998 Feb; 5(1):37-42. PubMed ID: 9816554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [C-reactive protein in patients with coronary heart disease].
    Rajtar R; Kolasińska-Kloch W; Kloch M
    Folia Med Cracov; 2004; 45(1-2):25-32. PubMed ID: 16276823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental evaluation of an enzymatic determination of lipids in the lipoprotein fractions obtained by electrophoresis and clinical investigation of alpha-lipoprotein lipids and serum apolipoprotein A in ischemic heart disease].
    Ikeda H; Maeda J
    Rinsho Byori; 1982 Oct; 30(10):1127-31. PubMed ID: 7182585
    [No Abstract]   [Full Text] [Related]  

  • 31. Apolipoprotein A-I in coronary-artery disease.
    N Engl J Med; 1984 Jan; 310(2):123-4. PubMed ID: 6419103
    [No Abstract]   [Full Text] [Related]  

  • 32. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.
    Yildirir A; Kabakci G; Can I; Erbas B
    Eur Heart J; 2001 Apr; 22(7):612-3. PubMed ID: 11259151
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum lipoprotein(a) levels in ischaemic heart disease.
    Singh RB
    J Assoc Physicians India; 1999 Aug; 47(8):846-7. PubMed ID: 10778647
    [No Abstract]   [Full Text] [Related]  

  • 34. [Genetic factors in ischemic heart disease].
    Slavchev S
    Vutr Boles; 1986; 25(3):12-9. PubMed ID: 3532554
    [No Abstract]   [Full Text] [Related]  

  • 35. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
    Miller M; Ginsberg HN; Schaefer EJ
    Am J Cardiol; 2008 Apr; 101(7):1003-8. PubMed ID: 18359322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
    St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease: the Bezafibrate Infarction Prevention Study.
    Haim M; Boyko V; Goldbourt U; Battler A; Behar S
    Arch Intern Med; 2004 Feb; 164(4):433-9. PubMed ID: 14980995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Apolipoproteins: valuable indicators of atherogenicity in patients with coronary disease and normal blood lipids].
    Mordasini R; Riesen W
    Ann Med Interne (Paris); 1983; 134(5):479-82. PubMed ID: 6418049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoproteins, lipoprotein subfractions, and the risk of coronary artery disease.
    Thompson WG
    South Med J; 1993 Feb; 86(2):194-200. PubMed ID: 8434292
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM; Hoogeveen RC
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.